Related Experiment Video
Updated: Nov 4, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Complications Associated With Intravenous Antibiotic Treatment for Cutibacterium acnes Periprosthetic Shoulder
Abstract:
Whether positive Cutibacterium acnes cultures during revision shoulder arthroplasty represent true periprosthetic joint infection (PJI), deep tissue inoculant, or laboratory contaminant is a point of substantial controversy. The purpose of this study was to review complications of intravenous antibiotics used for treatment of presumed C acnes shoulder PJI. A study population of 26 patients treated for C acnes PJI with a minimum follow-up of 2 years after operative treatment was established. Complication occurrence and severity were obtained through chart review and phone survey. Sixteen (61.5%) patients experienced a therapeutic complication. Twelve (46.2%) patients experienced a total of 47 antibiotic-associated adverse effects and 10 (38.5%) patients experienced 11 total peripherally inserted central catheter line-associated complications. Female sex carried an increased risk for severe complications (relative risk, 3.3; 95% CI, 1.2-9.5; P=.024). Treatment duration of greater than 6 weeks was a significant predictor for the total number of complications experienced [F(1,23)=5.361; P=.030; adjusted R2=0.189]. Age older than 65 years, treatment duration greater than 6 weeks, and female sex were significant predictors for the number of severe complications [F(3,21)=3.249; P=.042; adjusted R2=0.219]. Treating C acnes infection with intravenous antibiotics carries a substantial risk of adverse events, highlighting the importance of accurate diagnosis of shoulder PJI. Further investigations into the efficacy and safety profile of oral antibiotics for shoulder PJI are necessary. [Orthopedics. 2021;44(3):e422-e426.].
Insights
Intravenous antibiotics for presumed Cutibacterium acnes shoulder periprosthetic joint infection (PJI) led to significant complications in over 60% of patients. Female sex and longer treatment duration increased risks, necessitating careful diagnosis and exploration of oral antibiotic options.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Pharmacology
Background:
- The role of Cutibacterium acnes in shoulder periprosthetic joint infection (PJI) remains controversial, with uncertainty regarding true infection versus contamination.
- Intravenous antibiotic therapy is a common treatment for presumed C. acnes shoulder PJI, but its complication profile requires thorough investigation.
Purpose of the Study:
- To review the complications associated with intravenous antibiotic treatment for presumed C. acnes shoulder PJI.
- To identify risk factors for adverse events and severe complications in patients treated for C. acnes shoulder PJI.
Main Methods:
- Retrospective chart review and phone survey of 26 patients treated for C. acnes shoulder PJI with a minimum 2-year follow-up post-operatively.
- Data collection focused on therapeutic complications, antibiotic-associated adverse effects, and peripherally inserted central catheter (PICC) line complications.
Main Results:
- Over 60% of patients (16/26) experienced therapeutic complications.
- 46.2% of patients (12/26) suffered 47 antibiotic-associated adverse effects, and 38.5% (10/26) had 11 PICC line-associated complications.
- Female sex, age over 65, and treatment duration exceeding 6 weeks were significant predictors of total and severe complications.
Conclusions:
- Intravenous antibiotic treatment for C. acnes shoulder PJI carries a substantial risk of adverse events.
- Accurate diagnosis of shoulder PJI is crucial to avoid unnecessary and potentially harmful antibiotic exposure.
- Further research into the efficacy and safety of oral antibiotics for shoulder PJI is warranted.
Related Concept Videos
Endocarditis IV: Nursing Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Endocarditis I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

